{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T14:01:28Z","timestamp":1784815288390,"version":"3.55.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.taap.2026.117801","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T09:21:39Z","timestamp":1773825699000},"page":"117801","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Urinary NGAL as an early marker of subclinical kidney injury in adults with substance use disorder: A case\u2013control study"],"prefix":"10.1016","volume":"511","author":[{"given":"Mohammed S.","family":"Hemeda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amany Ahmed","family":"Moustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basma El-Sayed Abd","family":"El-Aal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba Youssef","family":"Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.taap.2026.117801_bb0005","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2215\/CJN.03530708","article-title":"Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage","volume":"4","author":"Bolignano","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.taap.2026.117801_bb0010","article-title":"STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies","volume":"351","author":"Bossuyt","year":"2015","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.taap.2026.117801_bb0015","first-page":"31","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"issue":"1","key":"10.1016\/j.taap.2026.117801_bb0020","doi-asserted-by":"crossref","DOI":"10.1186\/s12882-023-03120-6","article-title":"Diagnostic value of neutrophil gelatinase-associated lipocalin (NGAL) as an early biomarker for detection of renal failure in hypertensives: a case-control study in a regional hospital in Ghana","volume":"24","author":"Danquah","year":"2023","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.taap.2026.117801_bb0025","series-title":"Handbook of Chronic Kidney Disease Management","author":"Daugirdas","year":"2015"},{"issue":"9","key":"10.1016\/j.taap.2026.117801_bb0030","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nrneph.2013.143","article-title":"The applicability of eGFR equations to different populations","volume":"9","author":"Delanaye","year":"2013","journal-title":"Nat. Rev. Nephrol."},{"issue":"3","key":"10.1016\/j.taap.2026.117801_bb0035","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"issue":"2","key":"10.1016\/j.taap.2026.117801_bb0040","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2217\/bmm.10.12","article-title":"Neutrophil gelatinase-associated lipocalin: a promising biomarker for human acute kidney injury","volume":"4","author":"Devarajan","year":"2010","journal-title":"Biomark. Med"},{"issue":"2","key":"10.1016\/j.taap.2026.117801_bb0045","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"G*power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences","volume":"39","author":"Faul","year":"2007","journal-title":"Behav. Res. Methods"},{"issue":"3","key":"10.1016\/j.taap.2026.117801_bb0050","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/clinchem\/30.3.433","article-title":"Determination of sodium and potassium with ion-selective electrodes","volume":"30","author":"Fogh-Andersen","year":"1984","journal-title":"Clin. Chem."},{"issue":"6","key":"10.1016\/j.taap.2026.117801_bb0055","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/ckj\/sfu092","article-title":"Cocaine and kidney injury: a kaleidoscope of pathology","volume":"7","author":"Goel","year":"2014","journal-title":"Clin. Kidney J."},{"issue":"17","key":"10.1016\/j.taap.2026.117801_bb0060","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/j.jacc.2010.11.051","article-title":"The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: a multicenter pooled analysis of prospective studies","volume":"57","author":"Haase","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1\u20132","key":"10.1016\/j.taap.2026.117801_bb0065","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.clinbiochem.2012.09.022","article-title":"Day-to-day variation of urinary NGAL and rationale for creatinine correction","volume":"46","author":"Helmersson-Karlqvist","year":"2013","journal-title":"Clin. Biochem."},{"issue":"4","key":"10.1016\/j.taap.2026.117801_bb0070","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ccc.2012.07.008","article-title":"Toxidromes","volume":"28","author":"Holstege","year":"2012","journal-title":"Crit. Care Clin."},{"key":"10.1016\/j.taap.2026.117801_bb0075","series-title":"IBM SPSS Statistics for Windows. Version 26.0","author":"IBM Corp","year":"2020"},{"issue":"19","key":"10.1016\/j.taap.2026.117801_bb0080","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine- and cystatin C-based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"50","key":"10.1016\/j.taap.2026.117801_bb0085","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000031888","article-title":"Renal manifestations of recreational drugs: a narrative review of the literature","volume":"101","author":"Kannan","year":"2022","journal-title":"Medicine (Baltimore)"},{"issue":"4 Suppl","key":"10.1016\/j.taap.2026.117801_bb0090","first-page":"S117","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Chronic Kidney Disease Work Group","year":"2024","journal-title":"Kidney Int."},{"issue":"11","key":"10.1016\/j.taap.2026.117801_bb0095","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.282.11.1061","article-title":"Empirical evidence of design-related bias in studies of diagnostic tests","volume":"282","author":"Lijmer","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.taap.2026.117801_bb0100","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1186\/s12882-017-0794-0","article-title":"Systematic review of nephrotoxicity of drugs of abuse, 2005-2016","volume":"18","author":"Mansoor","year":"2017","journal-title":"BMC Nephrol."},{"issue":"3","key":"10.1016\/j.taap.2026.117801_bb0105","doi-asserted-by":"crossref","DOI":"10.1186\/cc13897","article-title":"Acute kidney injury due to rhabdomyolysis and renal replacement therapy: a critical review","volume":"18","author":"Petejova","year":"2014","journal-title":"Crit. Care"},{"key":"10.1016\/j.taap.2026.117801_bb0110","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jpsychires.2014.08.020","article-title":"Underestimation of substance use in psychiatric patients by conventional hospital screening","volume":"59","author":"Reidy","year":"2014","journal-title":"J. Psychiatr. Res."},{"issue":"4","key":"10.1016\/j.taap.2026.117801_bb0115","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1503\/cmaj.050090","article-title":"Evidence of bias and variation in diagnostic accuracy studies","volume":"174","author":"Rutjes","year":"2006","journal-title":"CMAJ"},{"key":"10.1016\/j.taap.2026.117801_bb0120","series-title":"Human NGAL ELISA Kit: Instruction Manual","author":"SunRed Biotechnology Company","year":"2026"},{"issue":"4","key":"10.1016\/j.taap.2026.117801_bb0125","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/jalm\/jfaa053","article-title":"Clinical and analytical impact of moving from Jaffe to enzymatic serum creatinine methodology","volume":"5","author":"Syme","year":"2020","journal-title":"J. Appl. Lab. Med."},{"issue":"1","key":"10.1016\/j.taap.2026.117801_bb0130","doi-asserted-by":"crossref","first-page":"7","DOI":"10.11622\/smedj.2015003","article-title":"Normalisation of urinary biomarkers to creatinine for clinical practice and research\u2014when and why","volume":"56","author":"Tang","year":"2015","journal-title":"Singapore Med. J."},{"issue":"9596","key":"10.1016\/j.taap.2026.117801_bb0135","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"issue":"20","key":"10.1016\/j.taap.2026.117801_bb0140","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World medical association declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X26000979?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X26000979?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T13:13:53Z","timestamp":1784812433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X26000979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":28,"alternative-id":["S0041008X26000979"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2026.117801","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urinary NGAL as an early marker of subclinical kidney injury in adults with substance use disorder: A case\u2013control study","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2026.117801","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117801"}}